[Treatment of rheumatic diseases with Prednirheumin-combi].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D006801:Humans; D010653:Phenylbutazone / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D010653:Phenylbutazone; D011241:Prednisone
Die Behandlung rheumatischer Erkrankungen mit Prednirheumin-kombi.